Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsBrian G. Till, Oliver W. Press, Andrew Raubitschek et al.|Blood|2008Cited by 719
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial resultsBrian G. Till, Oliver W. Press, Michael C. Jensen et al.|Blood|2012Cited by 530
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responsesMarcin Kortylewski, Hua Yu, Piotr Swiderski et al.|Nature Biotechnology|2009Cited by 378
Specific Recognition and Killing of Glioblastoma Multiforme by Interleukin 13-Zetakine Redirected Cytolytic T CellsKanwarpal Kahlon, Michael C. Jensen, Christine E. Brown et al.|Cancer Research|2004Cited by 367